Patient Cases. IM approach to Dementia. Dementia. Types of Dementia. Clinical Evaluation- History 9/24/2012

Size: px
Start display at page:

Download "Patient Cases. IM approach to Dementia. Dementia. Types of Dementia. Clinical Evaluation- History 9/24/2012"

Transcription

1 Patient Cases IM approach to Dementia Wendy Kohatsu, MD Sept yomale wife brings him in b/c he forgets things, loses his keys, gets lost in supermarket, and then tends to lose his temper easily. 59 yowoman h/o cognitive decline, MRI 2009 c/w significant atrophy. Rx: CoQ10, alpha lipoicacid, 1 gmomega-3, DHEA 100 mg, gingko, ginseng, Brain Fitness program, gardening; just got P.A.P. for donepezil (Aricept). Dementia Definition: Major impairment in learning and memory plus one of following: Impairment in handling complex tasks Impairment in reasoning Impairment in spatial ability and orientation Language impairment Severe enough to interfere with daily function (work, social, or relationships) NOT accounted for by other psychiatric or systemic disorder. Types of Dementia Alzheimer s disease (AD) % Vascular dementias (multiinfarct) 10-20% Other: Parkinsons 5% Alcohol-related Frontotemporal(Pick s Disease) Lewy-body (see rapid decline, hallucinations, motor def) Other neurodegenerations (e.g. Huntingtons) Neuroepidemiology 2007; 29:125 Clinical Evaluation- History Obtain a clear description of problem behavior, temporal onset, course, circumstances Assess ability to express basic needs (hunger, thirst, fatigue) R/o delirium acute/rapid change (dehydration, UTI, pneumonia, angina, constipation, pain, uncontrolled diabetes mellitus) 8 years average. Range 2-20 years 1

2 Clinical Evaluation- History Look for mood disturbance(sadness, irritability, withdraw) Check medications always suspect the meds Pain meds, anti-cholinergics, any psych meds, antihistamines Remember to ask about alcohol usein elderly. Ask about environmental precipitants: change in routine, roommate, caregiver, overstimulation/under-stimulation, other disruptive patients, family illness Clinical Evaluation- History Periodic testing with either MMSE or Clinical Dementia Rating (CDR) Draw-a-Clock test Consider neuropsych testing Testing must be socially relevant and appropriate for level of education Clinical Evaluation- Workup? Labs: Less than 1% yield AmerAcadNeurology suggests only TSH, B12 If Hxand exam indicate, RPR, CBC, CMP, heavy metals, Utox, CSF studies Neuroimaging: YES x1 NoncontrastCT or MRI of brain Can reveal CVD, neoplasm, hematoma, nl pressure hydrocephalus, also define areas of atrophy. Neurology. 2001;56(9):1143 Treatment basics: Treat underlying medical illness Correct sensory deficits Remove offending medications Keep environment comfortable, calm, homelike Regular daily activities, exercise and structure Assess sleep and eating patterns Educate and support caregiver Cholinesterase Inhibitors Mech: Inhibit Ach breakdown in brain Donepezil (Aricept ) qd* Less systemic anti-ach side effects Rivastigmine(Exelon ) BID Smidge better, best side effect profile Galantamine(Razadyne ) BID Better when mild mod dementia (MMSE 10-26) Cholinesterase Inhibitors Start low and go slow Most effective at highest doses but sideeffects increase too and can limit use. In the case of Alzheimer s disease improvement = slower decline May need addlmedications to address other sx: mood, agitation, sleep. However, dilemma of polypharmacy Goodol UpTo Date 2012 Ann Intern Med. 2008;148(5):379. 2

3 Cholinesterase Inhibitors SystRev mild improvement in cognition and global fxn, studies ~ 6 mos, no overall QOL difference However, % ptsmay show NO improvement Start with 8 week trial then re-assess Other pharma: Memantine(Namenda ) inhibits glutamate which acts as neurotoxin May help in later stages of AD Often added to anticholinesterase inhibitor Statins? Rotterdam study (n = 6992) Retrospective study cp statin users to never used.. HR 0.57 Degree of lipid improvement did not matter Animal studies show statins decrease level of amyloid protein in brain. However, Cochrane review of subsequent RCT s did not support. Statins started too late? J Neurol Neurosurg Psychiatry. 2009;80(1):13. Cochrane Database Syst Rev Gingko biloba RCT of 120 mg BID ginkgo cp to placebo N = 3000 pts, age 75 or older Followed up from No difference in rate of decline to AD Again, Rx started too late? JAMA. 2008;300(19):2253 JAMA. 2009;302(24):2663 Role of Prevention Prevention: Diet Mediterranean Diet (MeDi) --those with highest adherence had reduced risk of AD. Cplowest to Med tertile: HR 0.85 Cplowest to High tertile: HR 0.60 (n = 2258) MeDi also helps prevent mild cognitive impairment, 17 28% less risk over 4 years. (n = 1393) Ann Neurol. 2006;59(6):912. (MeDi diet) Arch Neurol. 2009;66(2):216. 3

4 Prevention: Diet Daily consumption of V/F showed reduced risk, HR Weekly fish consumption ~ HR 0.65 High omega 6 intake hazard ratio of 2.12 in high risk genetic group (Apo E epsilon 4 noncarriers) Healthy combo of F, V, nuts, poultry, fish showed HR 0.62 cpto red meat, butter, high fat dairy. Omega 3: DHA levels Framingham Heart Study. A prospective study n = 899 men and women, free of dementia at baseline, at mean 9.1 years Top quartile of plasma PC DHA showed 47% reduced risk of developing dementia of all causes Neurology. 2007;69(20):1921 Arch Neurol. 2010;67(6):699. Schaefer EJ, Arch Neurol Nov;63(11): Physical exercise & movement Crude cumulative incidence of dementia in subjects with baseline plasma phosphatidylcholine docosahexaenoic acid (PC DHA) levels in the upper quartile compared with those with levels in the lower 3 quartiles. Aerobic conditioning Increases cerebral blood flow Slows development of AD National Long-Term Care Study OR 0.55 to years f/u Walking (average 5x/week) and gardening (2-3x/week) most frequent activities Best if 20 minutes or longer Neurology 1998; 50:A89-A90. Alzheimers Dement 2010; 6: Physical Exercise RCT 24-week physical activity intervention vs education N=138, aged 50 years or older, mild cognitive dysfunction 6-month program of physical activity provided a modest improvement in cognition over an 18-month follow-up period Intervention group improved 0.73 points (95% confidence interval, to 0.03) on the ADAS-Cog versus 0.04 points in controls Lautenschlager NT, JAMA Sep 3;300(9):

5 Cognitive fitness Cognitive stimulation Music, art, crossword puzzles, headline discussion Mental training Can increase neuron dendrite sprouting Addlbenefit of social time with others J Neurosci Res 1975; 1: Hormone Replacement Rx DHEA Pregnenolone Estrogen? -- Huperzine A Natural anticholinesterase inhibitor from Chinese club moss Animal studies: surpassed effects of donepezil (Aricept ) in reversing memory deficits Low side effect profile Dose: 50 mg qd-bd Khalsa DS, Alzheimer Disease in Rakel, ed Integrative Medicine, 3 rd edition Meditation May mediate effects of chronic stress Cortisol cascade, affects hippocampus which regulates cortisol feedback Hippocampus volume inversely related to cortisol Meditators have less lipid peroxidase, higher DHEA, lower cortisol Lupien SJ et al. Nat Rev Neurosci 2009; 10: Horm Behav 1978; 10:54-60 Wallace RR. The Physiology of Consciousness. J Alzheimers Dis 2010; 20: Kirtan kriya Kirtan Developed by Yogi Bhajan SaaTaaNaaMaa 3 rd eye focus Mudras fingers 2,3,4,5 Cerebral blood flow changes during chanting meditation. Nucl Med Commun 2009; 30:

6 Pearls Definition: Memory impairment + other cognitive decline & impairs daily living REVIEW MEDS! Inquire about alcohol Obtain objective testing MMSE or other Caregiver support is critical. All Rx after horse is out of barn = minimal efx PREVENTION IS KING! DO recommend anti-inflmdiet, exercise, stress reduction, social connection. 6

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of

More information

Memory Loss, Dementia and Alzheimer's Disease: The Basics

Memory Loss, Dementia and Alzheimer's Disease: The Basics Memory Loss, Dementia and Alzheimer's Disease: The Basics What is memory loss? What is age-related memory loss? Typical changes Typical age-related changes involve: Making a bad decision once in a while

More information

Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved

Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved Defining Dementia Dementia is a group of symptoms affecting intellectual and social abilities severely

More information

The Basics of Alzheimer s Disease

The Basics of Alzheimer s Disease 2017 Memory Loss Conference The Basics of Alzheimer s Disease Tom Ala, MD Center for Alzheimer s Disease and Related Disorders Southern Illinois University School of Medicine Springfield, Illinois SIU

More information

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future Daniel S. Sitar Professor Emeritus University of Manitoba Email: Daniel.Sitar@umanitoba.ca March 6, 2018 INTRODUCTION EPIDEMIOLOGY

More information

Diagnosis and Treatment of Alzhiemer s Disease

Diagnosis and Treatment of Alzhiemer s Disease Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised

More information

Section Editor Steven T DeKosky, MD, FAAN Kenneth E Schmader, MD

Section Editor Steven T DeKosky, MD, FAAN Kenneth E Schmader, MD Prevention of dementia Author Daniel Press, MD Michael Alexander, MD Section Editor Steven T DeKosky, MD, FAAN Kenneth E Schmader, MD Deputy Editor Janet L Wilterdink, MD Last literature review version

More information

3/6/2019 DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING FINANCIAL DISCLOSURES LEARNING OBJECTIVES

3/6/2019 DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING FINANCIAL DISCLOSURES LEARNING OBJECTIVES DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING MILTA LITTLE, DO, CMD DUKE UNIVERSITY SCHOOL OF MEDICINE FINANCIAL DISCLOSURES Dr. Little has no relevant financial disclosures to report Dr. Little will

More information

BEHAVIORAL PROBLEMS IN DEMENTIA

BEHAVIORAL PROBLEMS IN DEMENTIA BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and

More information

Recognition and Management of Behavioral Disturbances in Dementia

Recognition and Management of Behavioral Disturbances in Dementia Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic

More information

Significance A Busy Clinician's Guide to Seniors with Memory Loss

Significance A Busy Clinician's Guide to Seniors with Memory Loss Significance A Busy Clinician's Guide to Seniors with Memory Loss Victoria Braund MD FACP CMD Division of Geriatrics. NorthShore University HealthSystem Alzheimer's disease is the sixth leading cause of

More information

HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?

HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE? EAMA CORE CURRICULUM HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE? Sofia Duque Orthogeriatric Unit São Francisco Xavier Hospital Occidental Lisbon Hospital Center University Geriatric Unit, Faculty of

More information

Assessing and Managing the Patient with Cognitive Decline

Assessing and Managing the Patient with Cognitive Decline Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor

More information

Nutritional intervention in early Alzheimer s disease. Sasha Newsam, PhD Global Medical Affairs Manager Nutricia

Nutritional intervention in early Alzheimer s disease. Sasha Newsam, PhD Global Medical Affairs Manager Nutricia Nutritional intervention in early Alzheimer s disease Sasha Newsam, PhD Global Medical Affairs Manager Nutricia Agenda Nutrition and brain function Single nutrient intervention Diet and risk of Alzheimer

More information

100 billion neurons!

100 billion neurons! 100 billion neurons! Where s my car parked? Normal Memory Changes with Age Memory changes start even before 30 Harder to store new memories Sensory inputs aren't as sharp hear, see, taste Multi-tasking

More information

Dementia Chronic Brain Failure The forgotten cardiovascular disease Clare Hawley 2015

Dementia Chronic Brain Failure The forgotten cardiovascular disease Clare Hawley 2015 Dementia Chronic Brain Failure The forgotten cardiovascular disease Clare Hawley 2015 MB ChB, MRCGP, PG Dip Cardiol, PG Cert Med Ed Associate Specialist Cardiology Chesterfield Royal Hospital GPwSI Refractory

More information

Drug Update. Treatments for Cognitive Impairment in the Older Adult. William Solan, M.D. Karen Sanders, Ph.D. Northwest Hospital Seattle

Drug Update. Treatments for Cognitive Impairment in the Older Adult. William Solan, M.D. Karen Sanders, Ph.D. Northwest Hospital Seattle Drug Update Treatments for Cognitive Impairment in the Older Adult William Solan, M.D. Karen Sanders, Ph.D. Northwest Hospital Seattle Current Drug Treatments for Alzheimer s Disease Cholinesterase Inhibitors:

More information

Dementia and Alzheimer s disease

Dementia and Alzheimer s disease Since 1960 Medicine Korat โรงพยาบาลมหาราชนครราชส มา Dementia and Alzheimer s disease Concise Reviews PAWUT MEKAWICHAI MD DEPARTMENT of MEDICINE MAHARAT NAKHON RATCHASIMA HOSPITAL 1 Prevalence Increase

More information

Michael A. Lobatz MD The Neurology Center Scripps Rehabilitation Center

Michael A. Lobatz MD The Neurology Center Scripps Rehabilitation Center Michael A. Lobatz MD The Neurology Center Scripps Rehabilitation Center Dementia an acquired syndrome consisting of a decline in memory and other cognitive functions Alzheimer s Disease Fronto temporal

More information

Brain Health Evidence-Successes of Communities Who Embraced Culture Change. Kim Butrum RN, MS, GNP Senior Vice President, Clinical Services

Brain Health Evidence-Successes of Communities Who Embraced Culture Change. Kim Butrum RN, MS, GNP Senior Vice President, Clinical Services Brain Health Evidence-Successes of Communities Who Embraced Culture Change Kim Butrum RN, MS, GNP Senior Vice President, Clinical Services Changing the culture in long-term memory care Long term memory

More information

4/11/2017. The impact of Alzheimer s disease. Typical changes. The impact of Alzheimer s disease. Problematic changes. Problematic changes

4/11/2017. The impact of Alzheimer s disease. Typical changes. The impact of Alzheimer s disease. Problematic changes. Problematic changes The impact of Alzheimer s disease Ron Petersen, MD, PhD, is Director of the Mayo Alzheimer's Disease Research Center. 2 The impact of Alzheimer s disease Typical changes Typical age-related changes involve:

More information

Alzheimer s Disease Update: From Treatment to Prevention

Alzheimer s Disease Update: From Treatment to Prevention Alzheimer s Disease Update: From Treatment to Prevention Jeffrey M. Burns, MD Edward H. Hashinger Professor of Medicine Co-Director, KU Alzheimer s Disease Center Director, Clinical and Translational Science

More information

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey ALZHEIMER S DISEASE Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey Topics Covered Demography Clinical manifestations Pathophysiology Diagnosis Treatment Future trends Prevalence and Impact

More information

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH EADC BRUNO VELLAS 14/01/05 10:14 Page 1 EADC OVERVIEW B. VELLAS & E. REYNISH (Toulouse, France, EU) Bruno Vellas: The European Alzheimer's Disease Consortium is a European funded network of centres of

More information

Mild Cognitive Impairment

Mild Cognitive Impairment Mild Cognitive Impairment The Role of the Family Physicians McGill Refresher Course December 2018 Fadi Massoud MD FRCPC, Internist-Geriatrician Centre Hospitalier Charles LeMoyne & Institut Universitaire

More information

Dementia Basics. Welcome! What to expect and how to handle a dementia diagnosis. In partnership with Scripps Health.

Dementia Basics. Welcome! What to expect and how to handle a dementia diagnosis. In partnership with Scripps Health. Dementia Basics What to expect and how to handle a dementia diagnosis March 18, 2017 In partnership with Scripps Health Welcome! 1 Welcome Kristin Gaspar San Diego County Supervisor District 3 2 Our Mission:

More information

A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies

A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies Lynda Mackin, PhD, AGPCNP-BC, CNS University of California San Francisco School of Nursing 1 Alzheimer s

More information

Alzheimer s disease dementia: a neuropsychological approach

Alzheimer s disease dementia: a neuropsychological approach Alzheimer s disease dementia: a neuropsychological approach Dr. Roberta Biundo, PhD Neuropsychology Coordinator at Parkinson s disease and movement disorders unit of San Camillo rehabilitation hospital

More information

Coconut Oil, Vitamins and Alzheimer s: What Really Works?

Coconut Oil, Vitamins and Alzheimer s: What Really Works? Program by Phone March 13, 2018 Coconut Oil, Vitamins and Alzheimer s: What Really Works? Robert L. Russell, MD Medical Director, Kindred at Home, Indianapolis, IN 1 OBJECTIVES To discuss how lifestyle

More information

Dementia: Diagnosis and Treatment

Dementia: Diagnosis and Treatment Dementia: Diagnosis and Treatment Outline 1. Risk factors and definition of dementia 2. Types of Dementias 3. MMSE and testing 4. Treatment options Cognitive decline with aging Mild changes in memory and

More information

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018 Dementia NICE Guidelines Update Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018 How NICE guidelines are reviewed Multidisciplinary guideline committee established Review

More information

What We Can Do To Prevent or Reduce the Risk for Dementia

What We Can Do To Prevent or Reduce the Risk for Dementia What We Can Do To Prevent or Reduce the Risk for Dementia Colloquium on Health and Wellness October 10 th, 2018 Frank M. Longo, MD, PhD Professor and Chair Department of Neurology and Neurological Sciences

More information

Evaluation and Treatment of Dementia

Evaluation and Treatment of Dementia Evaluation and Treatment of Dementia Jeffrey M. Burns, MD Edward H. Hashinger Professor of Neurology Co-Director, KU Alzheimer s Disease Center Director, Clinical and Translational Science Unit Disclosures

More information

Exercise and Lifestyle Factors Can cognitive decline & dementia be prevented? Henry Brodaty

Exercise and Lifestyle Factors Can cognitive decline & dementia be prevented? Henry Brodaty Partner logo here Exercise and Lifestyle Factors Can cognitive decline & dementia be prevented? Henry Brodaty Can we prevent dementia? The adult brain weighs about 1.3 kg Dementia shrinks it to 1/2 its

More information

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease What is PRESENTS DEMENTIA? WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: Memory Reasoning Planning Learning Attention Language Perception Behavior AS OF 2013 There

More information

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health ALZHEIMER S DISEASE OVERVIEW Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health Prevalence AD: DEMOGRAPHY AND CLINICAL FEATURES Risk and protective factors Clinical features and

More information

Dementia and Delirium: A Neurologist s Approach to Altered Mental Status. Case 1 4/7/11. Which of the following evaluations is your next step?

Dementia and Delirium: A Neurologist s Approach to Altered Mental Status. Case 1 4/7/11. Which of the following evaluations is your next step? Dementia and Delirium: A Neurologist s Approach to Altered Mental Status S. Andrew Josephson, MD Director, Neurohospitalist Program Medical Director, Inpatient Neurology University of California San Francisco

More information

OLD AGE PSYCHIATRY. Dementia definition TYPES OF DEMENTIA. Other causes. Psychiatric disorders of the elderly. Dementia.

OLD AGE PSYCHIATRY. Dementia definition TYPES OF DEMENTIA. Other causes. Psychiatric disorders of the elderly. Dementia. Psychiatric disorders of the elderly OLD AGE PSYCHIATRY Dementia Depression Delusional disorder/late onset schizophrenia Delirium Dementia definition LOCALISATION OF CEREBRAL FUNCTION Impairment of multiple

More information

The Better Health News2

The Better Health News2 February, 2009 Volume 4, Issue 1 The Better Health News2 Special Interest Articles: Curry and Disease Name That Food Nutrition and Disease Diet, Supplmentation and Dementia Elemental Diet and Crohn s Disease

More information

Delirium and Dementia. Summary

Delirium and Dementia. Summary Delirium and Dementia Paul Kettl, M.D., M.H.A. Summary DELIRIUM Acute brain failure Identify cause (meds, infection) Treat sx Poor prognostic sign DEMENTIA Chronic brain failure AD most common cause Often

More information

Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment (MCI) October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine

More information

NOTES. Developed by Fabio Comana, MA., MS., All rights Reserved Page 1

NOTES. Developed by Fabio Comana, MA., MS., All rights Reserved Page 1 Session 415: Brain Fitness Fabio Comana, MA., MS., NASM CPT, CES & PES; ACE CPT & LWMC; ACSM HFS, NSCA CSCS; CISSN National Academy of Sports Medicine fabio.comana@nasm.org Does research demonstrate a

More information

Alzheimer s Disease - Dementia

Alzheimer s Disease - Dementia - Dementia Neurocognitive disorder with dysfunction or loss of " Memory " Orientation " Attention " Language " Judgment " Reasoning Other characteristics that can manifest " Personality changes " Behavioral

More information

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER OVERCOMING THE CHALLENGES OF MANAGING CHRONIC DISEASES IN PERSONS WITH DEMENTIA DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER LEARNING OBJECTIVES Be familiar with the diagnostic criteria for

More information

10 Facts We All Need to Know About Dementia (MNCD) in Old Age

10 Facts We All Need to Know About Dementia (MNCD) in Old Age 10 Facts We All Need to Know About Dementia (MNCD) in Old Age DUNCAN ROBERTSON FRCP (LOND & EDIN) FRCPC MEDICAL ADVISOR TO ADVANCING DEMENTIA DIAGNOSIS AND MANAGEMENT IN ALBERTA AND PRIMARY HEALTH CARE

More information

Cal MediConnect Dementia Awareness CMC Annual Training

Cal MediConnect Dementia Awareness CMC Annual Training Cal MediConnect 2017 Dementia Awareness 2017 CMC Annual Training Definition Overview of Dementia Training Diagnosis of Dementia Signs and Symptoms Risk Factors Stages of Dementia Types of Dementia: Reversible/Irreversible

More information

Alzheimer Disease and Related Dementias

Alzheimer Disease and Related Dementias Alzheimer Disease and Related Dementias Defining Generic Key Terms and Concepts Mild cognitive impairment: (MCI) is a state of progressive memory loss after the age of 50 that is beyond what would be expected

More information

Understanding Symptoms, Causes, and Risks for Alzheimer s Disease

Understanding Symptoms, Causes, and Risks for Alzheimer s Disease Understanding Symptoms, Causes, and Risks for Alzheimer s Disease Gene E. Alexander, Ph.D., Professor of Psychology, Neuroscience, and Physiological Sciences; Director, Brain Imaging, Behavior & Aging

More information

Introduction to Dementia: Diagnosis & Evaluation. Created in March 2005 Duration: about 15 minutes

Introduction to Dementia: Diagnosis & Evaluation. Created in March 2005 Duration: about 15 minutes Introduction to Dementia: Diagnosis & Evaluation Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:

More information

Imaging of Alzheimer s Disease: State of the Art

Imaging of Alzheimer s Disease: State of the Art July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression

More information

NEUROPSYCHOMETRIC TESTS

NEUROPSYCHOMETRIC TESTS NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract

More information

What is dementia? What is dementia?

What is dementia? What is dementia? What is dementia? What is dementia? What is dementia? Dementia is an umbrella term for a range of progressive conditions that affect the brain. It has been identified that there are over 200 subtypes of

More information

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why? Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric

More information

MOVEMENT DISORDERS AND DEMENTIA

MOVEMENT DISORDERS AND DEMENTIA MOVEMENT DISORDERS AND DEMENTIA FOCUS ON DEMENTIA WITH LEWY BODIES MADHAVI THOMAS MD NORTH TEXAS MOVEMENT DISORDERS INSTITUTE, INC DEMENTIA de men tia dəˈmen(t)sh(ē)ə/ nounmedicine noun: dementia a chronic

More information

Form D1: Clinician Diagnosis

Form D1: Clinician Diagnosis Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.

More information

Memory Matters: Learning Objectives: Synapses, Age, and Health. Neuronal Synapses DISCLOSURE DECLARATION. Cognition and Normal Aging

Memory Matters: Learning Objectives: Synapses, Age, and Health. Neuronal Synapses DISCLOSURE DECLARATION. Cognition and Normal Aging Standard Deviations from Mean Memory Matters: Preventing and Treating Late-Life, Cognitive Decline Daniel L. Murman, MD, MS Director, Behavioral and Geriatric Neurology Program Professor & Vice Chair,

More information

Alzheimer s Disease. Pathophysiology: Alzheimer s disease (AD) is a progressive dementia affecting cognition, behavior,

Alzheimer s Disease. Pathophysiology: Alzheimer s disease (AD) is a progressive dementia affecting cognition, behavior, 2 Alzheimer s Disease Alzheimer s disease (AD) is a progressive dementia affecting cognition, behavior, and functional status with no known cause or cure. Patients eventually lose cognitive, analytical,

More information

Update on Dementia and Future Directions

Update on Dementia and Future Directions Update on Dementia and Future Directions Steven Tam, MD Assistant Clinical Professor Geriatrics/Internal Medicine UCI Medical Center/Senior Health Center April 17, 2014 Disclosure I have no financial relationships

More information

What is dementia? Symptoms of dementia. Memory problems

What is dementia? Symptoms of dementia. Memory problems What is dementia? What is dementia? What is dementia? Dementia is an umbrella term for a range of progressive conditions that affect the brain. The brain is made up of nerve cells (neurones) that communicate

More information

Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician

Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician Dementia Aetiology, pathophysiology and the role of neuropsychological testing Dr Sheng Ling Low Geriatrician Topics to cover Why is dementia important What is dementia Differentiate between dementia,

More information

Nutraceuticals & Lifestyle Changes That Can Halt The Progression Of Alzheimer s. by Dr. Gregory Smith

Nutraceuticals & Lifestyle Changes That Can Halt The Progression Of Alzheimer s. by Dr. Gregory Smith Nutraceuticals & Lifestyle Changes That Can Halt The Progression Of Alzheimer s by Dr. Gregory Smith DIET: Studies of dietary influences on Alzheimer's disease do not yet provide clear evidence. Also the

More information

Hyperlipidemia in an Otherwise Healthy 80 Year-Old Patient. Theodore D Fraker, Jr, MD Professor of Medicine

Hyperlipidemia in an Otherwise Healthy 80 Year-Old Patient. Theodore D Fraker, Jr, MD Professor of Medicine Hyperlipidemia in an Otherwise Healthy Theodore D Fraker, Jr, MD Professor of Medicine Orlando, Florida October 7-9, 2011 80-Year-Old Patient Primary Prevention Issues in the Elderly: Coronary artery disease

More information

Understanding the potential of cognitive ingredients. Dr Carrie Ruxton Freelance Dietitian

Understanding the potential of cognitive ingredients. Dr Carrie Ruxton Freelance Dietitian Understanding the potential of cognitive ingredients Dr Carrie Ruxton Freelance Dietitian Cognitive health important across the lifecycle Higher IQ Diet & Supplements Brain development Slower cognitive

More information

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits Overview Overview Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits The differential diagnosis of Parkinson s disease Primary vs. Secondary Parkinsonism Proteinopathies:

More information

11/11/2016. Disclosures. Natural history of BPSD. Objectives. Assessment of BPSD. Behavioral Management of Persons with Alzheimer s Disease

11/11/2016. Disclosures. Natural history of BPSD. Objectives. Assessment of BPSD. Behavioral Management of Persons with Alzheimer s Disease Disclosures Behavioral Management of Persons with Alzheimer s Disease Wisconsin Association of Medical Directors November 17, 2016 Art Walaszek, M.D. Professor of Psychiatry UW School of Medicine & Public

More information

What is dementia? What is dementia?

What is dementia? What is dementia? What is dementia? What is dementia? What is dementia? Dementia is an umbrella term for a range of progressive conditions that affect the brain. There are over 200 subtypes of dementia, but the five most

More information

Practical Matters in the Care of A Person with Dementia

Practical Matters in the Care of A Person with Dementia Practical Matters in the Care of A Person with Dementia 7 th Annual Neurology Update for Primary Care Deborah S. Hoffnung, PhD, ABPP CN November 16, 2018 1 Typical Aging, MCI/CIND, dementia Common Dementia

More information

11/12/2018. Acknowledgements. Risk factors for Alzheimer s disease

11/12/2018. Acknowledgements. Risk factors for Alzheimer s disease Is it Possible to Reduce My Risk for Alzheimer's Disease? An Overview of Current Risk Reduction Strategies Dorothy Farrar Edwards PhD, Professor of Medicine and Kinesiology Core Leader: Outreach, Recruitment

More information

Dr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen. Dr. Michael Plopper. Dr. Guerry Peavy

Dr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen. Dr. Michael Plopper. Dr. Guerry Peavy 1 Anne State 2 3 Dr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen Dr. Michael Plopper Dr. Guerry Peavy 4 Michael Lobatz, MD Medical Director, Neurosciences Medical Director, Rehabilitation

More information

Dementia and Delirium:

Dementia and Delirium: Dementia and Delirium: A Neurologist s Approach to Altered Mental Status S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Senior Executive

More information

Dementia. Understanding 9/20/2010. Jan Robson Coordinator of the Alzheimer Society's Dementia Helpline

Dementia. Understanding 9/20/2010. Jan Robson Coordinator of the Alzheimer Society's Dementia Helpline Understanding Dementia Jan Robson Coordinator of the Alzheimer Society's Dementia Helpline Marc Labrecque Provincial Coordinator of Programs and Services 1 Understanding Dementia What is dementia Alzheimer

More information

AGED SPECIFIC ASSESSMENT TOOLS. Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services

AGED SPECIFIC ASSESSMENT TOOLS. Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services AGED SPECIFIC ASSESSMENT TOOLS Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services Issues in assessing the Elderly Association between biological, psychological, social and cultural

More information

Caring Sheet #11: Alzheimer s Disease:

Caring Sheet #11: Alzheimer s Disease: CARING SHEETS: Caring Sheet #11: Alzheimer s Disease: A Summary of Information and Intervention Suggestions with an Emphasis on Cognition By Shelly E. Weaverdyck, PhD Introduction This caring sheet focuses

More information

Behavioral Aspects of Parkinson s Disease

Behavioral Aspects of Parkinson s Disease Behavioral Aspects of Parkinson s Disease Joseph H. Friedman, MD Director, Movement Disorders Program Butler Hospital Dept of Neurology Alpert Medical School of Brown University 1 Disclosures Drugs will

More information

Risk Factors Associated with Cognitive Aging. Andrea Z. LaCroix, PhD. for the IOM Committee on the Public Health Dimensions of Cognitive Aging

Risk Factors Associated with Cognitive Aging. Andrea Z. LaCroix, PhD. for the IOM Committee on the Public Health Dimensions of Cognitive Aging Risk Factors Associated with Cognitive Aging Andrea Z. LaCroix, PhD. for the IOM Committee on the Public Health Dimensions of Cognitive Aging Lifestyle and Physical Environment Risk & Protective Factors

More information

Depression: An Important Risk Factor for Cognitive Decline

Depression: An Important Risk Factor for Cognitive Decline Depression: An Important Risk Factor for Cognitive Decline No conflicts of interest Sarah K. Tighe, M.D. Assistant Professor University of Iowa Carver College of Medicine Department of Psychiatry Institute

More information

Geriatric Alterations Associated with Neurological Conditions

Geriatric Alterations Associated with Neurological Conditions Geriatric Alterations Associated with Neurological Conditions I have no conflicts of interest. Julie Bronson The Older Adult According to the World Health Organization Africa 50-55 or 50-65 United Nations

More information

Alzheimer Disease and Related Dementias. Alzheimer Society of Manitoba Dr. David Strang

Alzheimer Disease and Related Dementias. Alzheimer Society of Manitoba Dr. David Strang Alzheimer Disease and Related Dementias Alzheimer Society of Manitoba Dr. David Strang What is Dementia? Dementia is a syndrome symptoms include loss of memory, judgment and reasoning, and changes in mood

More information

ANTIOXIDANT SUPPLEMENTS IN ALZHEIMER S DEMENTIA AND MILD COGNITIVE IMPAIRMENT: A SYSTEMATIC REVIEW

ANTIOXIDANT SUPPLEMENTS IN ALZHEIMER S DEMENTIA AND MILD COGNITIVE IMPAIRMENT: A SYSTEMATIC REVIEW Journal of Aging Research & Clinical Practice Volume 6, 2017 J Aging Res Clin Practice 2017;6:1-8 Published online December 1, 2016, http://dx.doi.org/10.14283/jarcp.2016.121 ANTIOXIDANT SUPPLEMENTS IN

More information

8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research

8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research The Evolving Concept of Alzheimer s Disease David S. Geldmacher, MD, FACP Warren Family Endowed Chair in Neurology Department of Neurology UAB School of Medicine Epochs of AD Research Epoch Years Key Event

More information

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) A. The development of multiple cognitive deficits manifested by both 1 and 2 1 1. Memory impairment 2. One (or more) of the following

More information

15/10/2018. A Functional Approach to Neurodegeneration. Functional Medicine for Alzheimer s Patients. Belinda Reynolds B.Sc.Nut.Diet.

15/10/2018. A Functional Approach to Neurodegeneration. Functional Medicine for Alzheimer s Patients. Belinda Reynolds B.Sc.Nut.Diet. A Functional Approach to Neurodegeneration Belinda Reynolds B.Sc.Nut.Diet. (Hons) 1 Functional Medicine for Alzheimer s Patients Source: http://www.dailymail.co.uk/health/article-3644980/scientists-reverse-memory-loss-time-alzheimer-spatients-changes-sleep-diet-medication-exercise.html

More information

A New Theory of Aging. Understanding Cognition. Train the Brain?

A New Theory of Aging. Understanding Cognition. Train the Brain? Strong Minds: Exercise & Cognitive Function A New Theory of Aging Cognitive decline is not an inevitable part of aging. Vascular dementia is directly related to poor blood flow & oxygeb delivery to brain

More information

Update in the Diagnosis, Treatment and Prevention of Alzheimer s Disease. Conflicts of Interest

Update in the Diagnosis, Treatment and Prevention of Alzheimer s Disease. Conflicts of Interest Update in the Diagnosis, Treatment and Prevention of Alzheimer s Disease Katherine Julian, M.D. Associate Clinical Professor of Medicine University of California, San Francisco July 4, 2012 Conflicts of

More information

Dementia is not normal aging!

Dementia is not normal aging! The Future of Alzheimer s Disease Treatment Adam L. Boxer, MD, PhD Director, Alzheimer s Disease Clinical Trials Program Memory and Aging Center Assistant Professor of Neurology University of California,

More information

The Person: Dementia Basics

The Person: Dementia Basics The Person: Dementia Basics Objectives 1. Discuss how expected age related changes in the brain might affect an individual's cognition and functioning 2. Discuss how changes in the brain due to Alzheimer

More information

UDS version 3 Summary of major changes to UDS form packets

UDS version 3 Summary of major changes to UDS form packets UDS version 3 Summary of major changes to UDS form packets from version 2 to VERSION 3 february 18 final Form A1: Subject demographics Updated question on principal referral source to add additional options

More information

Ranking Nutritional Supplements Botanical Medicine Primary

Ranking Nutritional Supplements Botanical Medicine Primary Your Monthly Update Dear Colleague Welcome to the October newsletter from Pure Bio Ltd. Did you know...? The UK organic market grew by 30% and averaged sales of 7million a week in 2005! Our topic for this

More information

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT RUTH KOHEN ASSOCIATE PROFESSOR UW DEPARTMENT OF PSYCHIATRY 5-4-2017

More information

A Dynamic Model of Care for Late Onset Cognitive Impairment. Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong

A Dynamic Model of Care for Late Onset Cognitive Impairment. Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong A Dynamic Model of Care for Late Onset Cognitive Impairment Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong Outline The pathogenesis of Late life cognitive impairment A framework

More information

Delirium in the ICU: Prevention and Treatment. Delirium Defined Officially. Delirium: Really Defined. S. Andrew Josephson, MD

Delirium in the ICU: Prevention and Treatment. Delirium Defined Officially. Delirium: Really Defined. S. Andrew Josephson, MD Delirium in the ICU: Prevention and Treatment S. Andrew Josephson, MD Director, Neurohospitalist Service Medical Director, Inpatient Neurology June 2, 2011 Delirium Defined Officially (DSM-IV-TR) criteria

More information

T H E B E T T E R H E A L T H N E W S

T H E B E T T E R H E A L T H N E W S Dr. Paul G. Varnas & WholeHealthAmerica.com present V O L U M E 7, I S S U E 2 T H E B E T T E R H E A L T H N E W S F E B R U A R Y, 2 0 1 0 D E M E N T I A A N D E X E R C I S E L E T S H E A R I T F

More information

Cognitive disorders. Dr S. Mashaphu Department of Psychiatry

Cognitive disorders. Dr S. Mashaphu Department of Psychiatry Cognitive disorders Dr S. Mashaphu Department of Psychiatry Delirium Syndrome characterised by: Disturbance of consciousness Impaired attention Change in cognition Develops over hours-days Fluctuates during

More information

Protecting Brain Health: Chronic Dz Prevention, Risk Management in Alzheimer s Disease

Protecting Brain Health: Chronic Dz Prevention, Risk Management in Alzheimer s Disease Protecting Brain Health: Chronic Dz Prevention, Risk Management in Alzheimer s Disease Victor A. Hirth, MD, MHA, FACP, AGSF Professor & Chief Division of Geriatrics USC, School of Medicine Medical Director

More information

After the Diagnosis: Rehabilitation & Support Options for Mild Dementia

After the Diagnosis: Rehabilitation & Support Options for Mild Dementia After the Diagnosis: Rehabilitation & Support Options for Mild Dementia Dr. Toni Nicholls, Clinical Neuropsychologist Peronne Village, cottage #20, Worthing, Christ Church 621-2022 Say these aloud Dog

More information

Test your Knowledge: Recognizing Delirium

Test your Knowledge: Recognizing Delirium The Ottawa Hospital Name: Unit: Profession: RN RPN PT OT SW Other Note: Each question has only one correct answer. 1. If a patient is identified as being at high risk for developing delirium, his/her mental

More information

Next patient please Dementia Clare Hawley 2018

Next patient please Dementia Clare Hawley 2018 Next patient please Dementia Clare Hawley 2018 I have no conflict of interest to declare Dr Clare Hawley Associate Specialist Cardiology Chesterfield Royal Hospital GPwSI Refractory Angina Hon Clinical

More information

If you have dementia, you may have some or all of the following symptoms.

If you have dementia, you may have some or all of the following symptoms. About Dementia Dementia may be caused by a number of illnesses that affect the brain. Dementia typically leads to memory loss, inability to do everyday things, difficulty in communication, confusion, frustration,

More information

Behavioral Interventions

Behavioral Interventions Behavioral Interventions Linda K. Shumaker, R.N.-BC, MA Pennsylvania Behavioral Health and Aging Coalition Behavioral Management is the key in taking care of anyone with a Dementia! Mental Health Issues

More information

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease The current state of healthcare for Normal Aging, g, Mild Cognitive Impairment, & Alzheimer s Disease William Rodman Shankle, MS MD FACP Director, Alzheimer s Program, Hoag Neurosciences Institute Neurologist,

More information